This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1 NAPNAP contact hour, of which 1.0 is pharmacology.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2018 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Keywords: seizures, epilepsy, anti-epileptic medications
Pediatric-focused advanced practice registered nurses
• Review the history of seizure treatment and discuss this evolution based on drug action and efficacy.
• Describe the mechanism of action of the newest anti-seizure medication and compare these drugs to those previously prescribed.
• Identify the most effective, evidence-based anti-epileptic drugs and list potential side effects of the older and newest therapies.
Catherine Haut, DNP, CPNP-AC-PC, CCRN, FAANP: Nurse Practitioner, Beacon Pediatrics, Rehoboth Beach, Del.; Research Director, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Del.
There are no disclosures to report for Catherine Haut.
- 1.00 Contact hours